← Eichor
Condition: Recurrent Low Grade Glioma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Recurrent Low Grade Glioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
NA · 1 location(s) · University of California, San Francisco · NCT07506239Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Glioma
EARLY_Phase 1 · 1 location(s) · Daniel Morgenstern · NCT06381570MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
Phase 1/Phase 2 · 3 location(s) · Ann & Robert H Lurie Children's Hospital of Chicago · NCT06712875A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours
Phase 1 · 6 location(s) · Ipsen · NCT07441707Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
Phase 1 · 17 location(s) · University of California, San Francisco · NCT04485559A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma
Phase 2 · 35 location(s) · Day One Biopharmaceuticals, Inc. · NCT04775485ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Phase 1 · 1 location(s) · Katy Peters, MD, PhD · NCT05609994SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Phase 1/Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT04923126Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
Phase 2 · 7 location(s) · University of California, San Francisco · NCT07110246A Vaccine Trial for Low Grade Gliomas
Phase 2 · 1 location(s) · James Felker · NCT02358187
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.